Covestor’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Covestor's IRMD Position: Q2 2026 in Review
Covestor increased its iRadimed (IRMD) stake by 40% in Q2 2026, buying an estimated $364 and bringing the position to 14 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.
Covestor first reported a position in IRMD in Q3 2022 and has held it in 14 quarters since. The position peaked at $3K in Q4 2024. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Covestor held 14 shares of iRadimed worth $1K as of Q2 2026.
- Covestor bought 4 iRadimed shares in Q2 2026, an estimated $364.
- iRadimed made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2201 holding.
- Covestor first reported a position in iRadimed in Q3 2022 and has held it in 14 quarters since.
- Covestor's iRadimed position peaked at $3K in Q4 2024.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.